Huang Dennis Karl
See Remarks | EVP &Chief Tech Ops Officer | SVP And Chief Tech Ops Officer +1 more
1 company
Insider Signal Score
63
GoodTrades Analyzed
4
12M Win Rate
75.0%
Avg 3M Return
+15.6%
Avg 12M Return
+30.9%
Huang Dennis Karl is a See Remarks at Ultragenyx Pharmaceutical Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $3.8M based on current market prices.
Holdings by Company
RAREApr 16, 2026
Current Shares147.8K
Value$3.82M
Net Activity-8,861
Bought: 0Sold: 8.9K
Transaction History
Showing 6 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 389 | $45.65 | $17,757.85 | -0.5% | +6.0% | +13.3% | |
| Mar 1, 2022 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 3,234 | $66.62 | $215,449.08 | -8.1% | -30.4% | -32.2% | |
| Oct 14, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP &Chief Tech Ops Officer | Sell | 358 | $81.14 | $29,048.12 | -0.9% | -12.1% | -54.2% | |
| May 6, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP &Chief Tech Ops Officer | Sell | 363 | $113.68 | $41,265.84 | -0.9% | -26.2% | -50.3% | |
| Mar 1, 2021 | RARE Ultragenyx Pharmaceutical Inc. | EVP &Chief Tech Ops Officer | Sell | 4,255 | $138.18 | $587,955.90 | -9.5% | - | - | |
| Oct 14, 2020 | RARE Ultragenyx Pharmaceutical Inc. | EVP &Chief Tech Ops Officer | Sell | 262 | $88.00 | $23,056.00 | -0.7% | - | - |